NCT06072170View on ClinicalTrials.gov

Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions
SafetyPharmacokineticsPharmacodynamics
Interventions
DRUG

Kratom

Single administration thirty minutes after the start of a high-fat breakfast

DRUG

Placebo

Single administration thirty minutes after the start of a high-fat breakfast

Trial Locations (1)

66212

Altasciences Clinical Kansas, Inc., Overland Park

All Listed Sponsors
lead

Altasciences Company Inc.

INDUSTRY